SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003051
Filing Date
2018-04-23
Accepted
2018-04-23 09:00:30
Documents
9
Period of Report
2018-06-06
Effectiveness Date
2018-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235300zdef14a.htm DEF 14A 298187
2 G29942BGI001.GIF g29942bgi001.gif GRAPHIC 148178
3 G29942BGI002.GIF g29942bgi002.gif GRAPHIC 65971
4 G700527.JPG g700527.jpg GRAPHIC 4723
5 G283559.JPG g283559.jpg GRAPHIC 748
6 G926711.JPG g926711.jpg GRAPHIC 802
7 G171131.JPG g171131.jpg GRAPHIC 3949
8 G198114.JPG g198114.jpg GRAPHIC 3272
9 G603824.JPG g603824.jpg GRAPHIC 3928
  Complete submission text file 0001047469-18-003051.txt   619250
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37526 | Film No.: 18768027
SIC: 2834 Pharmaceutical Preparations